(Q39367887)

English

Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Meg Perumal

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Euan A Stronach

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hani Gabra

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Eric O Aboagye

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Molecular Imaging and Biology

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

753-761

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Emerging drugs for ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Guidelines for the welfare and use of animals in cancer research

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Early detection of tumor response to chemotherapy by 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

GSK690693 delays tumor onset and progression in genetically defined mouse models expressing activated Akt.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Drugging the PI3 kinome

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Ovarian cancer: strategies for overcoming resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Targeting the phosphoinositide 3-kinase pathway in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Monitoring predominantly cytostatic treatment response with 18F-FDG PET.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

18F-FDG PET/CT evaluation of patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods

1 reference

https://api.crossref.org/works/10.1007%2FS11307-012-0554-2

21 January 2018

In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization and properties of nine human ovarian adenocarcinoma cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484552

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-012-0554-2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39367887&oldid=2202812783"